Top Markets
#1 Black Phoenix Black Phoenix +167.53%
#2 Islamic Coin Islamic Coin +158.30%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +29.49%
#5 Test Test +23.70%
#6 Cryptopia Cryptopia +20.92%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.38%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +17.98%
#9 Steem Steem +13.65%
#10 MarsCoin MarsCoin +9.72%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.

ARYX
Classificação em ações #41544
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc.... Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.
Preço da ação
$0.0005
Última sincronização: 2026-08-11
Valor de mercado
$16.73K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar ARYx Therapeutics, Inc. (ARYX)

Categoria

Healthcare
Preço ARYX com a capitalização de mercado de B
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
ARYX
$0.0005
Capitalização de mercado de ARYx Therapeutics, Inc.(ARYX)
Valor de mercado: $16.73K
Em August 2026, ARYx Therapeutics, Inc. tem uma capitalização de mercado de $16.73K. Isso faz com que ARYx Therapeutics, Inc. seja a 41544th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de ARYx Therapeutics, Inc. de 2007 a 2026
ARYX comparado com o topo de 5 mais populares stocks
Preço para ARYX Ativo B Capitalização de mercado de B Resultados
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$160,880 $16.73K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +32,175,957,463.80%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$132,191 $16.73K
Apple Inc. Apple Inc.
AAPL
$4.423T +26,438,295,302.18%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$124,331 $16.73K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +24,866,232,636.13%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$109,477 $16.73K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +21,895,408,644.25%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$86,403.35 $16.73K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +17,280,669,288.56%